Tag Archives:


Its path to approval has all the features of a heavyweight healthcare fight – desperate patients demanding access to a promising therapy a very expensive drug that extends life only a few months and efficacy data open to interpretation. The … Continue reading

Posted in Prostate Health | Tagged | Comments Off on Proventr